Bortezomib (Velcade) With Standard Chemotherapy for Relapsed or Refractory Follicular Lymphoma

NCT00510887 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

14

Enrollment

OTHER

Sponsor class

Stopped Low accrual.

Conditions

Lymphoma, Follicular

Interventions

DRUG: Bortezomib
DRUG: Rituximab
DRUG: Fludarabine
DRUG: Mitoxantrone
DRUG: Dexamethasone

Sponsor

Duke University

Collaborators

[object Object]